These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 17666649)

  • 21. Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study.
    Brito LG; Candido-dos-Reis FJ; Magario FA; Sabino-de-Freitas MM
    Ultrasound Obstet Gynecol; 2012 Jul; 40(1):119-20. PubMed ID: 22102490
    [No Abstract]   [Full Text] [Related]  

  • 22. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

  • 23. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
    Hilário SG; Bozzini N; Borsari R; Baracat EC
    Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.
    Leunen M; Breugelmans M; De Sutter P; Bourgain C; Amy JJ
    Gynecol Oncol; 2004 Dec; 95(3):769-71. PubMed ID: 15582003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor.
    Takeda T; Masuhara K; Kamiura S
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):491-3. PubMed ID: 18669776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization.
    Iihara K; Hirano K; Fujioka Y; Sakamoto A
    Pathol Int; 2007 Oct; 57(10):681-7. PubMed ID: 17803657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of metastatic uterine leiomyosarcoma and carcinosarcoma in a single institute.
    Yoshinaga M; Togami S; Tsuji T; Fukamachi N; Kamio M; Yanagi M; Douchi T
    J Obstet Gynaecol Res; 2007 Dec; 33(6):818-22. PubMed ID: 18001448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.
    Lipton A; Leitzel K; Chaudri-Ross HA; Evans DB; Ali SM; Demers L; Hamer P; Brown-Shimer S; Pierce K; Gaur V; Carney W
    J Clin Oncol; 2008 Jun; 26(16):2653-8. PubMed ID: 18443351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of aged recurrent breast cancer with multiple lung metastases responding to examestane monotherapy].
    Imamura S; Aso M; Sakata H; Katoh H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):361-4. PubMed ID: 16531719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine leiomyosarcoma metastasizing to the heart.
    Tunio MA; Al-Asiri M; Fareed MM
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S20-1. PubMed ID: 24717993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone dependency in metastatic low-grade leiomyosarcoma following uterine smooth muscle tumour of uncertain malignant potential.
    Serrano C; Nucci MR; Tirumani SH; Raut CP; George S
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24675802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
    Erkanli S; Kayaselcuk F; Kuscu E; Bolat F; Sakalli H; Haberal A
    Breast; 2006 Aug; 15(4):558-61. PubMed ID: 16311034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
    Bellone S; Shah HR; McKenney JK; Stone PJ; Santin AD
    Am J Obstet Gynecol; 2008 Sep; 199(3):e7-e10. PubMed ID: 18550023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital.
    Dinh TA; Oliva EA; Fuller AF; Lee H; Goodman A
    Gynecol Oncol; 2004 Feb; 92(2):648-52. PubMed ID: 14766261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endometrial stromal sarcoma: complete response to therapy with aromatase-inhibitor, anastrozole].
    Lisianskaia AS; Manikhas GM; Fadeeva EP; Fedosenko KV; Tapil'skaia NI
    Vopr Onkol; 2010; 56(1):91-3. PubMed ID: 20361625
    [No Abstract]   [Full Text] [Related]  

  • 36. Metastasis of uterine leiomyosarcoma to the pancreas.
    Iwamoto I; Fujino T; Higashi Y; Tsuji T; Nakamura N; Komokata T; Douchi T
    J Obstet Gynaecol Res; 2005 Dec; 31(6):531-4. PubMed ID: 16343254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lung leiomyosarcoma 21 years after hysterectomy for uterine leiomyosarcoma: late metastasis?].
    de Dios A; Iglesias Felip C; Rodríguez Cros J; González Pérez J
    Med Clin (Barc); 1999 Dec; 113(19):755-6. PubMed ID: 10680131
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the BIG results: the Breast International Group 1-98 trial analyses.
    Doughty JC
    Breast; 2008 Jan; 17 Suppl 1():S9-S14. PubMed ID: 18279765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.